A shadow market for unapproved slimming medications is being driven by TikTok fitness influencers and sellers on messaging platforms, according to recent findings.
Experimental Drug Acquiring Traction Online
The experimental drug, which is still in clinical trials, is being advertised by online personalities for its alleged weight-reducing effects. Viewers are encouraged to message these profiles privately for source information, while also obtaining discount codes.
Active Trade on Social Networks
Separately, a flourishing market exists on Telegram, where communities with thousands of members share “before and after” images, administration instructions and assertions of rapid UK delivery. Vendors promote the substance there before redirecting buyers to other platforms for purchases.
Learning About Retatrutide
Retatrutide is an experimental injection created by US drugmaker Eli Lilly. The treatment targets three gut hormones – GLP-1, GIP and glucagon. Preliminary studies indicate it could help individuals lose up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being promoted online as the next Ozempic.
Healthcare Experts Express Concerns
However, physicians and chemists have warned that the sale of what is still an unapproved drug in the United Kingdom is a cause for concern and could lead to individuals administering substances of uncertain source.
Some professionals stated the popularity for the experimental drug could be linked to the increasing cost of licensed weight loss treatments such as Mounjaro.
Regulatory Status and Enforcement
Selling the unapproved drug on social media or Telegram is illegal in the United Kingdom, as it is an unlicensed drug that must not be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.
Some influencers attempt to sidestep the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but advertising and distribution can still breach pharmaceutical, marketing, and customer regulations, risking fines, prosecution or imprisonment.
Platform Reaction and Material Elimination
Based on the social media company, the service has removed violative material and banned related keywords and query recommendations. The company stated it was dedicated to keeping the service secure and investing in enhancing compliance measures.
Digital Trading Activities
Investigations also found communities with up to 9,000 participants marketing the experimental drug using the platform's integrated search feature, which functions like a online catalog. Entering “retatrutide” instantly displays groups with thousands of users, populated with images of slimming results, positive testimonials and detailed guides for mixing or administering at home.
After moments of entering one group, a vendor posted WhatsApp details, where the majority of purchases occur. The vendor sent an instruction manual and promised shipping within 48 hours. When questioned whether the product was authentic, one seller responded: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. Not one inquired about weight, medical conditions or previous experience.
Product Details and Pricing
Inside these communities, posts show black plastic packages with postal service stickers, claiming to include fresh supplies. One message read: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, mixed at home with purified liquid, or ready-to-use pens usually sold at £160 for 20 milligrams. When questioned how much time a injector should be used, vendors give conflicting responses ranging from a several days to “depends on your body”.
Service Moderation and Safety Actions
A representative for Telegram stated it actively moderated dangerous content on its service including content that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Medical Expert Warnings
“Individuals are injecting substances they can’t verify. Even if the research behind retatrutide is sound, these digital versions may not include what they advertise,” stated a pharmacy expert, the head of pharmaceutical services at Chemist4U.
A medical professional of Asda Online Doctor linked the surge in demand to recent price rises for approved slimming medications such as Mounjaro. “With prices rising, individuals are using social media. But fake treatments are extremely dangerous. You cannot know what’s inside or whether the conditions they were produced in was sterile,” she said.
Her team has previously seen patients harmed by self-injection from unverified sources. “We understand the disappointment, but buying from messaging apps or WhatsApp is gambling with your well-being,” said the doctor. “These substances could be contaminated or improperly measured.”
Producer Statement
A spokesperson from Eli Lilly stated retatrutide was in third stage research studies and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Therefore at this point no one can market [it] for human use,” they said, adding that any product “misleadingly claiming itself as a company investigational product not yet authorized … may expose patients to potentially significant medical dangers”.
